CJ Bioscience, Inc. (KOSDAQ:311690)

CJ Bioscience Revenue

In the year 2025, CJ Bioscience had annual revenue of 3.69B KRW with 6.52% growth. CJ Bioscience had revenue of 1.26B in the quarter ending December 31, 2025, with 33.65% growth.

• Revenue: 3.69B
• Revenue Growth: +6.52%
• P/S Ratio: 19.92
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 73.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.69B	225.99M	6.52%
Dec 31, 2024	3.47B	-2.11B	-37.82%
Dec 31, 2023	5.58B	1.50B	36.82%
Dec 31, 2022	4.07B	-288.37M	-6.61%
Dec 31, 2021	4.36B	-948.52M	-17.86%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 28, 2026

Data Sources Report a data error